And where are the similar studies for stroke? If we had reached the Tipping Point for stroke that a Great stroke association would have accomplished this would be in the works for stroke also. If you are a stroke association board member, Why are you allowing such incompetency in your organization?
http://consumer.healthday.com/Article.asp?AID=672492#.UPgipPulieM.facebook
Four U.S. government-funded clinical trials will search for new therapies for Alzheimer's disease.
The five-year effort will look at drug and exercise treatments for
patients with early stage disease, test if the generic drug prazosin can
reduce agitation in Alzheimer's patients, and examine a new approach to
speed testing of drugs in clinical trials.
The trials, which could cost as much as $55 million, are projects of
the Alzheimer's Disease Cooperative Study (ADCS), a consortium of
academic medical centers and clinics established in 1991 by the U.S.
National Institutes of Health.
The consortium, which includes more than 70 sites in the United
States and Canada, focuses on research of diagnosis and treatment
methods that might not be tested by the drug industry.
The four studies are among efforts to accomplish the research goals
outlined in the National Plan to Address Alzheimer's Disease, which was
announced in May 2012. The plan calls for a coordinated and focused
effort in research, care and services for Alzheimer's and related types
of dementia. The goal is to find ways to prevent and effectively treat
Alzheimer's by 2025.
"The ADCS is a key initiative in the federal program to discover,
develop and test new Alzheimer's treatments and diagnostic tools. Over
the years, it has proved invaluable in advancing our understanding about
the disease and how to conduct research in this challenging area," Dr.
Richard Hodes, director of the National Institute on Aging, said in an
NIH news release.
"I am particularly excited that this round of studies will use what
we have learned by testing interventions pre-symptomatically, as early
as we can in the development of the disease, where we now think the best
hope lies for keeping Alzheimer's at bay," he added.
SOURCE: U.S. National Institutes of Health, news release, Jan. 14, 2013
No comments:
Post a Comment